https://www.biospace.com/cellectis-and-cytovia-partner-to-develop-natural-killer-cells
Shares of Cellectis Therapeutics were up nearly 10% in premarket trading after the company forged a deal with Cytovia Therapeutics to develop immunotherapies...
natural killer cellcellectisstockjumpsfollowing
https://www.macrotrends.net/stocks/charts/CLLS/cellectis-sa/price-sales
Historical PS ratio values for Cellectis S.A (CLLS) over the last 10 years. The current P/S ratio for Cellectis S.A as of February 06, 2026 is...
cellectispricesalesratio
https://simplywall.st/stocks/fr/pharmaceuticals-biotech/epa-alcls/cellectis-shares/news/individual-investors-are-cellectis-sas-epaalcls-biggest-owne
Key Insights Cellectis' significant individual investors ownership suggests that the key decisions are influenced by...
individual investorscellectisepabiggest
https://www.biospace.com/cellectis-ucart19-first-in-man-proof-of-concept-to-be-presented-at-2015-american-society-of-hematology-annual-meeting
cellectisfirstmanproofconcept